Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
KYNB is expected to report earnings to fall 212.50% to -332 cents per share on November 09
Q3'26
Est.
$-3.33
Q2'26
Beat
by $6.14
Q1'26
Missed
by $3.55
Q4'25
Missed
by $3.37
The last earnings report on August 13 showed earnings per share of $2.96, beating the estimate of -318 cents. With 20.98K shares outstanding, the current market capitalization sits at 30.45M.